baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out ATO/ DE000SH6DE56 /

10/9/2024 10:05:50 AM	Chg.-	Bid10:00:37 PM	Ask10:00:37 PM	Underlying	Strike price	Expiration date	Option type
2.74EUR	-	- Bid Size: -	- Ask Size: -	Atos SE	28.0572 EUR	12/31/2078	Put

GlobeNewswire 8/28 Atossa Therapeutics Granted Additional Patent Protection for Endoxifen

GlobeNewswire 8/21 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...

GlobeNewswire 8/20 Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Publi...

GlobeNewswire 8/14 Stevie® Awards Announce Winners in The 21st Annual International Business Awards® from Across the Gl...

GlobeNewswire 8/12 Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 7/30 HUMAN Releases The Quadrillion Report: 2024 Cyberthreat Benchmarks, Uncovers Nearly 150 Million Comp...

GlobeNewswire 7/22 Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE...

GlobeNewswire 7/2 Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer

GlobeNewswire 6/28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...

GlobeNewswire 6/17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024

GlobeNewswire 6/11 Pythian Welcomes Brooks Borcherding as Chief Executive Officer

GlobeNewswire 6/5 Atossa to Present at the Sidoti Small-Cap Investor Conference

GlobeNewswire 5/30 Groundbreaking Technology Solves Major Problem of User Lockouts During MFA Resets

GlobeNewswire 5/28 NetLogistik Wins Partner Leadership Award from Blue Yonder

GlobeNewswire 5/28 Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast...

GlobeNewswire 5/16 Nametag Enlisted by Newfold Digital in the Fight Against Fraud and Cybersecurity Threats

GlobeNewswire 5/15 Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Tria...

GlobeNewswire 5/15 Calian Reports Record Results for the Second Quarter

GlobeNewswire 5/13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 5/13 NVIDIA Grace Hopper Ignites New Era of AI Supercomputing

GlobeNewswire 5/7 Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines

GlobeNewswire 4/29 Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...

GlobeNewswire 4/15 Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...

GlobeNewswire 4/11 Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference

Soc. Generale Knock-Out ATO/ DE000SH6DE56 /

If you wish to receive reply to your feedback, please provide your email address.